Champions Oncology Inc. | Income Statement
Fiscal year is May-April. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
11,550.00
8,863.00
11,182.00
15,411.00
20,241.00
Cost of Goods Sold (COGS) incl. D&A
6,263.00
7,633.00
8,686.00
9,703.00
10,553.00
Gross Income
5,287.00
1,230.00
2,496.00
5,708.00
9,688.00
SG&A Expense
11,547.00
14,468.00
12,812.00
12,517.00
11,042.00
EBIT
6,260.00
13,238.00
10,316.00
6,809.00
1,354.00
Unusual Expense
965.00
981.00
-
-
-
Non Operating Income/Expense
164.00
756.00
38.00
56.00
89.00
Pretax Income
7,389.00
13,013.00
10,354.00
6,865.00
1,443.00
Income Tax
17.00
127.00
92.00
19.00
33.00
Consolidated Net Income
7,406.00
13,140.00
10,446.00
6,884.00
1,476.00
Net Income
7,406.00
13,140.00
10,446.00
6,884.00
1,476.00
Net Income After Extraordinaries
7,406.00
13,140.00
10,446.00
6,884.00
1,476.00
Net Income Available to Common
7,406.00
13,140.00
10,446.00
6,884.00
1,476.00
EPS (Basic)
1.33
2.20
1.20
0.64
0.13
Basic Shares Outstanding
5,572.00
5,985.30
8,695.20
10,684.40
10,991.10
EPS (Diluted)
1.33
2.20
1.20
0.64
0.13
Diluted Shares Outstanding
5,572.00
6,424.40
8,695.20
10,684.40
10,991.10
EBITDA
6,047.00
13,024.00
10,160.00
6,641.00
994.00
About Champions Oncology
View Profile
